Cargando…
Systematic review and meta-analysis of third-line salvage therapy for the treatment of advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials
PURPOSE: We performed a systematic review and meta-analysis to investigate the efficacy of third-line treatment for advanced non-small-cell lung cancer (NSCLC). MATERIALS AND METHODS: Relevant trials were identified by searching electronic databases and conference meetings. Prospective randomized co...
Autores principales: | Zhang, Nan, Guo, Nan, Tian, Liang, Miao, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226041/ https://www.ncbi.nlm.nih.gov/pubmed/30459935 http://dx.doi.org/10.18632/oncotarget.24967 |
Ejemplares similares
-
Front-line treatment for advanced non-small-cell lung cancer and ALK
fusion: a network meta-analysis
por: Wen, Yaokai, et al.
Publicado: (2022) -
Neoadjuvant chemotherapy followed by surgery versus upfront surgery in non-metastatic non-small cell lung cancer: systematic review and meta-analysis of randomized controlled trials
por: Zhang, Xiao-Nan, et al.
Publicado: (2017) -
MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017) -
Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
por: Han, Yue, et al.
Publicado: (2021) -
Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50%
por: Freemantle, Nick, et al.
Publicado: (2022)